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Abstract  
We examined the prevalence of macroglossia in 65 patients with amyotrophic lateral 
sclerosis (ALS) on tracheostomy invasive ventilation (TIV).  Macroglossia was found in 22 
patients (33.8%).  Multivariate analysis showed that both body mass index (BMI) and 
communication impairment were significantly correlated with macroglossia.  Macroglossia 
might be the result of overfeeding and replacement by fat during long-term TIV use in 
patients with advanced ALS. 
 
 
1. Background 
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects upper and 
lower motor neurons.  Degenerative changes associated with ALS include the hypoglossal 
  
neurons, resulting in atrophy, weakness, and tongue fasciculations.  Tongue enlargement 
(macroglossia) was reported 2 patients with advanced ALS who were supported by 
tracheostomy-invasive ventilation (TIV), and tongue biopsy revealed marked degeneration of 
muscle fascicles accompanied by fatty replacement.
 1
   We speculated that macroglossia in 
ALS was associated with an energy imbalance and abnormal fat accumulation due to disease 
progression and excessive energy intake during TIV use. 
 
 
2. Subjects and Methods  
Sixty-five ALS patients (36 men and 29 women) on TIV participated cross-sectionally in 
the study.  We investigated absence or presence of macroglossia, and its relationship with 
various clinical parameters including duration of TIV use, body mass index (BMI), energy 
intake, communication impairment, and oral functions.  
As one of the indices of disease stage during TIV use, we adopted the staging of 
communication impairment according to previous studies
 2, 3
: stage I—communicates using 
sentences; stage II—communicates using 1-word answers only; stage III—only 
communicates using nonverbal yes / no responses; stage IV—only communicates 
occasionally with uncertain nonverbal yes/no responses; and stage V—unable to 
communicate by any means.  Stage V indicates a totally locked-in state (TLS) with total 
quadriplegia and complete loss of ocular movements.  We then classified patients into 3 
subgroups of stages I, II–IV, and V.  We also assessed the scores of the ALS Functional 
Rating Scale—revised (ALSFRS-R).4   
 
Macroglossia and Oral Functions : We evaluated the absence or presence of macroglossia 
in each patient.  Because a quantitative analysis of tongue size was not possible, we defined 
it as a condition in which the tongue always protruded over the patient’s dentition and the 
patient could not retract the tongue into the oral cavity.  Although tongue retraction is related 
  
to motor function, we considered it to be related to macroglossia, because hypoglossal nerve 
dysfunction usually causes atrophy and retraction of the tongue rather than protrusion.   
We also assessed oral and perioral functions in each patient with the Japanese version of 
the Norris Bulbar Scale, which has been validated as having high reliability for practical 
use.
5,6
  Oral and perioral movements were graded as “possible” or “impossible,” with 
“possible” indicating any slight movement. 
 
Statistical Analysis : Patients were classified into 2 subgroups based on the presence or 
absence of macroglossia.  Data were compared between the subgroups using the Mann–
Whitney U-test or chisquare test.  After determining significant factors in these comparisons, 
we analyzed which factors independently correlated with the occurrence of macroglossia. 
Because oral or perioral functions were expressed as “possible” or “impossible” (categorical 
variables) and considered to be strongly correlated with tongue functions, they were excluded 
from the logistic analysis.  After checking the variance inflation factor for multicollinearity 
between significant independent factors in the comparison analyses, we performed a 
multivariate logistic regression analysis.  All analyses were performed using Predictive 
Analytics Software (PASW) Statistics version 22.0 (IBM SPSS, Armonk, New York).  
P<0.05 was considered significant for all statistical analyses. 
 
 
3. Results 
The duration of TIV use was 77.7 ± 46.4 months (mean ± SD) for all patients.  Total 
ALSFRS-R scores were 0 in 44 patients, 1 in 7 patients, 2 in 13 patients, and 3 in 1 patient.  
The scores could only be counted for the items of drooling and swallowing.  Regarding 
communication impairment, 16 (24.6%) patients were in stage V.  No patients had obvious 
generalized edema, anemia, or hypoalbuminemia. 
Macroglossia was identified in 22 patients (33.8%).  A comparison of patients with and 
  
without macroglossia revealed that the former had a significantly younger age of onset (57.9 
vs. 64.1 years (ys) in average) (p=0.012), longer total disease duration from onset to the time 
of the examination (139.6 vs. 93.4 months (ms)) (p=0.002), younger age at the time of TIV 
initiation (60.4 vs. 67.0 ys) (p=0.002), and longer duration of TIV use (108.8 vs. 61.8 ms) (p< 
0.0001), lower ALS functional rating scales revised (0.3 vs. 0.7) (p=0.036), higher BMI (20.5 
vs. 18.1 kg/m
2
) (p=0.001), lower energy intake (920 vs. 990 kcal/day) (p=0.041) than the 
latter.  In addition, the former showed more advanced communication impairment, and more 
severe oral dysfunction including disabilities of lip and perioral movements, cheek 
blowing-out movement, tongue and jaw movements, compared with the latter.  In logistic 
multivariate analysis, BMI (p=0.007) and communication impairment stages (p=0.029) had 
significant effects on the appearance of macroglossia. 
 
 
4. Conclusions 
Macroglossia may be the result of overfeeding and replacement by fat during longterm TIV 
use in patients with advanced ALS. 
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